Pure Global AI
NCT06330532Recruitment Completed

Impact of Preoperative Frailty and Cognitive Impairment on Postoperative Outcomes in Elderly Cardiac Surgery Patients

Yonsei UniversityClinicalTrials.gov
Study focus
Study type
Observational
Sponsor & location
Primary sponsor
Yonsei University
Location
Seoul, South Korea
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
Feb 28, 2025
Enrollment
450 participants
Primary outcome

postoperative all cause mortality,major composite morbidity

Summary

This is a retrospective study of patients aged 65 years and older who underwent cardiac and
 aortic surgery between March 5, 2021 and October 12, 2022 in the operating room of Severance
 Cardiovascular Hospital to determine the impact of physical frailty as well as nutritional
 status, emotional dysregulation, and cognitive dysfunction on postoperative outcomes.
 Physical frailty will be determined by the Clinical Frailty Scale, handgrip strength, and
 nutritional status, cognitive dysfunction will be determined by the K-MMSE and K-MoCA
 administered at the preoperative interview, and emotional dysregulation will be determined
 using the SGDS-K. These were measured during the pre-anesthesia evaluation and only results
 from patients who agreed to be tested will be used. Nutritional status will be analyzed based
 on blood test values measured within one month of surgery.

ICD-10 classifications
Cardiovascular disease, unspecifiedHypertensive heart diseaseOther ill-defined heart diseasesHeart disease, unspecifiedObservation for other suspected cardiovascular diseases
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06330532
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06330532 through Pure Global AI's free database. This phase not specified trial is sponsored by Yonsei University and is currently Recruitment Completed. The study focuses on Cardiovascular Diseases. Target enrollment is 450 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.